Myriad Genetics Inc. (MYGN) Tops Q3 EPS by 6c, Raises FY11 Guidance

May 3, 2011 4:27 PM

Myriad Genetics Inc. (NASDAQ: MYGN) reported Q3 EPS of $0.31, $0.06 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found